Valuation: Ginwa Enterprise (Group) Inc.

Market Cap 1.7B 254M 221M 209M 190M 355M 24.34B 357M 2.5B 966M 12.38B 953M 932M 39.82B P/E 2024
37.4x
P/E 2025 171x
Enterprise Value 1.35B 201M 175M 165M 150M 281M 19.28B 283M 1.98B 765M 9.8B 755M 738M 31.53B EV / Sales 2024
4.15x
EV / Sales 2025 4.24x
Free-Float
62.32%
Yield 2024
0.38%
Yield 2025 0.4%
1 day+0.85%
1 week-0.62%
Current month-1.85%
1 month-0.42%
3 months+3.47%
6 months-44.98%
Current year-36.74%
1 week 4.64
Extreme 4.64
4.87
1 month 4.64
Extreme 4.64
5.13
Current year 4.26
Extreme 4.26
9.3
1 year 4.26
Extreme 4.26
9.35
3 years 4.26
Extreme 4.26
9.35
5 years 4.26
Extreme 4.26
10.97
10 years 3.7
Extreme 3.7
14.93
Manager TitleAgeSince
Chief Executive Officer 59 29/06/2020
Director of Finance/CFO 44 10/04/2025
Corporate Officer/Principal 30 16/02/2022
Director TitleAgeSince
Director/Board Member 63 21/04/2011
Chairman 59 22/02/2022
Director/Board Member 53 04/03/2022
Change 5-day change 1-year change 3-year change Capi.($)
+0.85%-0.62%-33.29%-35.45% 251M
+0.04%+3.34%+51.12%+101.82% 1,027B
-0.09%+1.66%+55.02%+66.18% 651B
-0.02%+2.66%+18.91%+71.47% 467B
-1.22%+3.66%+36.44%+38.32% 350B
-0.79%+2.73%+19.03%+25.08% 268B
+0.58%+6.76%+11.13%+16.52% 257B
+1.55%+2.20%+39.81%+46.55% 205B
+0.79%+1.84%-28.27%-56.71% 190B
-0.52%+4.45%+32.12%+98.51% 187B
Average +0.27%+2.54%+20.20%+37.23% 360.24B
Weighted average by Cap. +0.23%+3.01%+35.17%+61.80%

Financials

2024 2025
Net sales 585M 87.36M 76.18M 71.93M 65.32M 122M 8.38B 123M 862M 332M 4.26B 328M 321M 13.71B 544M 81.18M 70.79M 66.84M 60.7M 114M 7.79B 114M 801M 309M 3.96B 305M 298M 12.74B
Net income 74.61M 11.13M 9.71M 9.17M 8.32M 15.6M 1.07B 15.66M 110M 42.37M 543M 41.82M 40.89M 1.75B 15.58M 2.32M 2.03M 1.91M 1.74M 3.26M 223M 3.27M 22.92M 8.85M 113M 8.73M 8.54M 365M
Net Debt -327M -48.72M -42.48M -40.11M -36.43M -68.25M -4.67B -68.53M -481M -185M -2.38B -183M -179M -7.65B -354M -52.82M -46.06M -43.49M -39.49M -73.99M -5.07B -74.3M -521M -201M -2.58B -198M -194M -8.29B
Logo Ginwa Enterprise (Group) Inc.
Ginwa Enterprise Group Inc is a China-based company principally engaged in the research and development, production and sales of pharmaceuticals. The Company operates its businesses through three segments. The Pharmaceutical Industry segment is mainly engaged in the production of pharmaceuticals. The Company's products are divided into four series, including orthopedics, immunology, children's and general medicines, mainly covering chemicals, Chinese patent medicines, active pharmaceutical ingredient and health care products. The Hotel Industry segment is mainly engaged in the operation of hotels. The Pharmaceutical Commercial segment is mainly engaged in the sales of pharmaceuticals. The Company mainly operates its businesses in the domestic market.
Employees
613
Date Price Change Volume
18/09/26 CN¥4.770 +0.85% 1,436,800
17/09/26 CN¥4.730 -0.63% 1,143,800
16/09/26 CN¥4.760 +1.49% 2,323,758
15/09/26 CN¥4.690 -2.90% 2,435,700
14/09/26 CN¥4.830 +0.63% 1,110,700
  1. Stock Market
  2. Stocks
  3. 600080 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!